Carna Biosciences (TSE:4572) Institutional Ownership: 0.32% (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4572 Carna Biosciences Inc TSE:4572
40 GF Score
Price 円306.00
GF Value 円185.38
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Institutional Ownership?

Carna Biosciences TSE:4572 +0.99% 40 Institutional Ownership is 0.32% as of Aug. 04, 2026. GuruFocus rates TSE:4572 with a GF Score™ of 40/100 and a GF Value™ of 円185.38 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Carna Biosciences's institutional ownership is 0.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Carna Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Carna Biosciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Carna Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Institutional Ownership Chart

Carna Biosciences Historical Data

The historical data trend for Carna Biosciences can be seen below:

2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30
Institutional Ownership 1.59 1.18 1.15 1.13 1.13 1.11 1.09 1.11 0.36 0.32
TSE:4572
40GF Score
Carna Biosciences Inc TSE:4572
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.32% mean?
Carna Biosciences (TSE:4572) has a Institutional Ownership of 0.32% as of Aug. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Carna Biosciences and its competitors.
Is Carna Biosciences' Institutional Ownership too high?
Carna Biosciences' current Institutional Ownership is 0.32%. Overall, Carna Biosciences has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Institutional Ownership compare to VRTX and REGN?
Carna Biosciences' Institutional Ownership of 0.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Institutional Ownership is 0.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円185.38, compared to a current price of 円306.00 — trading 65.1% above its estimated fair value. The current Institutional Ownership is 0.32%. Carna Biosciences' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Institutional Ownership is 0.32% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円306.00 is trading 65.1% above its estimated GF Value™ of 円185.38. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Institutional Ownership: 0.32%
  • GF Value™: 円185.38 vs. price of 円306.00 (65.1% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
40GF Score

Get the complete analysis for TSE:4572

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円306.00
Price
円185.38
GF Value